国药控股24年收入-2.02%,利润-22.1%(繁体版)

第一上海
28 Mar

24年收入-2.02%,归母利润-22.1%:公司2024年收入同比下降2.02%至5845.1亿元,公司毛利率同比下降0.56pts至7.57%。销售、行政费率和财务费率维持稳定在2.94%、1.44%和0.4%。公司经营利润率同比下降0.62个百分点至2.77%。另公司今年资产处置收益为0.47亿(23年同期为6.6亿元)。24年公司无形资产减值11.1亿元(23年为0.4亿),其中国大药房...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10